Evaxion A/S (NASDAQ: EVAX) announced preclinical data for EVX-04, an experimental therapeutic vaccine for acute myeloid leukemia. The Copenhagen-based biotechnology ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA